ART AND SCIENCE IN CARDIOVASCULAR DISEASE

Authors

  • Cătălina ARSENESCU-GEORGESCU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Carmen-Elena PLEȘOIANU “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

As the progress in technology and pharmaceutical domain resulted in effective solutions for transmissible diseases such as cholera or poliomyelitis which caused mil-lions of deaths worldwide in the past, the importance of cardiovascular disease was brought into the spotlight. Many lifesaving interventions such the percutaneous angio-plasties in acute myocardial infarction led to an important impact in the survival rates increasing longevity. Furthermore, the prevention of cardiovascular disease has proven to be both effective and cost-efficient. The 2016 “European Guidelines on Cardiovascular Disease Prevention in Clinical Practice” clearly states that stop-ping smoking is the most cost-effective strategy for cardiovascular disease preven-tion (1).

References

1. Massimo F. Piepoli, Arno W. Hoes, Stefan Agewall et al. 2016 European Guidelines on cardiovascu-lar disease prevention in clinical practice. Eur Heart J 2016; 37(29): 2315-2381. 2. ***Global Atlas on Cardiovascular Disease Prevention and Control. Mendis S, Puska P, Norrving B editors. World Health Organization (in collaboration with the World Heart Federation and World Stroke Organization), Geneva 2011. 3. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009; 16(2): 121-137.
4. Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, Wollum A, Sanman E, Wulf S, Lopez AD, Murray CJ, Gakidou E. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014; 311(2): 183-192.
5. Goodchild M, Nargis N, Tursan d’Espaignet E. Tob Control 2017: 1-7. Published Online First: 17.06.2017 doi:10.1136/ tobaccocontrol-2016- 053305. 6. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.
7. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Buai A, Pais P, Variqos J and Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952. 8. Routh HB, Bhowmik KR, Parish JL, Parish LC. Historical aspects of tobacco use and smoking. Clin Dermatol. 1998; 16(5): 539-544.
9. Tempel B. Symbol and Images: Smoking in Art since the Seventeenth Century. Smoke. A Global History of Smoking edited by Sander L Gilman and Zhou Xun, 206-215.
10. Larsen IF Smoking and art. History of smoking in Norway in paintings. Tidsskr Nor Laegeforen 1997; 117(30): 4418-4421.
11. Wilson N, Sloane K, Thomson G. Brief Report: Might artworks from online-museum collections contribute to medical education? http://www.otago.ac.nz/wellington/otago086640.pdf 12. Wilson N, Thomson G. The decline of smoking in British portraiture. Tob Control. 2004; 13(1): 3-5.
13. Mekemson C, Glantz SA. How the tobacco industry built its relationship with Hollywood. Tobacco Control 2002; 11(Suppl I): i81-i91.
14. Richards R, UNK. We are about to go into production with the motion picture, “Run Sheep Run”, A suspense, thriller, set in Los Angeles. RJ Reynolds; August 25, 1972. Access date: March 26, 2001. Bates No. 500201423-1424. URL: http://www.rjrtdocs.com/.
15. Kelly Weedon Shute Advertising. Philip Morris cigarette marketing - a new perspective. Kelly Weedon Shute Advertising; November 1989. Access date: March 28, 2001. Bates No. 2501057693-7719. URL: http://www.pmdocs.com/getallimg.asp?DOCID=2501057693-7719).
16. Cowan W. I’m sorry we didn’t get to see each other last week when I was on my way back from Puerto Rico, but your secretary said you were out of town. R.J. Reynolds; May 4, 1981: Access date: March 27, 2001.Bates No. 503579240 -9244. URL: http://www.rjrtdocs.com/.
17. ***Philip Morris. List by year of movies for which product was supplied in connection with Charles Pomerantz and Andrew Varela. Philip Morris; March 1, 1989: Access date: March 30, 2001. Bates No. 2025863645-3659. URL: http://www.pmdocs.com/ getallimg.asp?DOCID=2025863645/3659.
18. Charlesworth A and Glantz S.A. Smoking in the Movies Increases Adolescent Smoking: A Review. Pediatrics 2005; 116; 1516-1528.
19. McIntosh WD, Bazzini DG, Smith SM, Wayne SM. Who smokes in Hollywood? Characteristics of smokers in popular films from 1940 to 1989. Addict Behav 1998; 23(3): 395-398.
20. Sargent JD, Dalton MA, Beach ML, Mott LA, Tickle JJ, Ahrens MB,Heatherton TF. Viewing tobac-co use in movies: does it shape attitudes that mediate adolescent smoking? Am J Prev Med 2002; 22(3): 137-145
21. Glantz SA. Smoking in the movies: a major problem and a real solution (published correction appears in Lancet. 2004; 363: 250). Lancet 2003; 362: 258-259
22. ***Centers for Disease Control and Prevention. Annual smoking attributable mortality, years of potential life lost, and economic costs: United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002; 51: 300-303.
23. Leonardi-Bee J, Nderi M, Britton J. Smoking in movies and smoking initiation in adolescents: sys-tematic review and meta-analysis. Addiction 2016; 111(10): 1750-1763.

Additional Files

Published

2017-09-30